Decoding TG Therapeutics's Options Activity: What's the Big Picture?
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
From the overall spotted trades, 2 are puts, for a total amount of $112,780 and 9, calls, for a total amount of $344,146.Whales with a lot of money to spend have taken a noticeably bullish stance on TG Therapeutics.
拥有大量资金的鲸鱼对TG Therapeutics持有明显看好态度。
Looking at options history for TG Therapeutics (NASDAQ:TGTX) we detected 11 trades.
查看TG Therapeutics (纳斯达克：TGTX) 期权历史，我们检测到11次交易。
If we consider the specifics of each trade, it is accurate to state that 63% of the investors opened trades with bullish expectations and 36% with bearish.
如果我们考虑每次交易的具体情况，准确地说，63%的投资者对看涨持有期权交易，36%的投资者持有看跌期权。
From the overall spotted trades, 2 are puts, for a total amount of $112,780 and 9, calls, for a total amount of $344,146.
从总体交易中，有2个看跌期权，总金额为112,780美元，9个看涨期权，总金额为344,146美元。
Predicted Price Range
预测价格区间
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $35.0 for TG Therapeutics over the last 3 months.
考虑到这些合约的成交量和未平仓合约量，过去3个月中鲸鱼一直在瞄准TG Therapeutics的目标价区间在15.0美元至35.0美元之间。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
In terms of liquidity and interest, the mean open interest for TG Therapeutics options trades today is 1441.83 with a total volume of 2,936.00.
就流动性和利润而言，今天TG Therapeutics期权交易的平均未平仓合约量为1441.83，总成交量为2,936.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for TG Therapeutics's big money trades within a strike price range of $15.0 to $35.0 over the last 30 days.
在下面的图表中，我们能够跟踪过去30天TG Therapeutics大额期权交易中看涨期权和看跌期权的成交量和未平仓合约量在15.0美元至35.0美元的行权价格范围内的发展情况。
TG Therapeutics Option Volume And Open Interest Over Last 30 Days
TG Therapeutics过去30天的期权成交量和未平仓合约量
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | PUT | SWEEP | BEARISH | 09/20/24 | $2.15 | $1.25 | $1.25 | $21.00 | $70.0K | 152 | 628 |
| TGTX | CALL | TRADE | BULLISH | 01/17/25 | $7.5 | $7.3 | $7.5 | $20.00 | $52.5K | 5.6K | 171 |
| TGTX | CALL | SWEEP | BEARISH | 01/17/25 | $7.8 | $7.5 | $7.56 | $20.00 | $46.9K | 5.6K | 101 |
| TGTX | CALL | TRADE | BULLISH | 01/17/25 | $7.2 | $7.0 | $7.2 | $20.00 | $46.8K | 5.6K | 236 |
| TGTX | CALL | TRADE | BULLISH | 01/17/25 | $7.4 | $7.2 | $7.4 | $20.00 | $44.4K | 5.6K | 296 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | 看跌 | SWEEP | 看淡 | 09/20/24 | $2.15 | $1.25 | $1.25 | 21.00美元 | $70.0K | 152 | 628 |
| TGTX | 看涨 | 交易 | 看好 | 01/17/25 | $7.5 | $7.3 | $7.5 | $20.00 | $52.5K | 5.6K | 171 |
| TGTX | 看涨 | SWEEP | 看淡 | 01/17/25 | $7.8 | $7.5 | $7.56 | $20.00 | $46.9K | 5.6K | 101 |
| TGTX | 看涨 | 交易 | 看好 | 01/17/25 | $7.2 | $7.0 | $7.2 | $20.00 | $46.8K | 5.6K | 236 |
| TGTX | 看涨 | 交易 | 看好 | 01/17/25 | $7.4 | $7.2 | $7.4 | $20.00 | $44.4千美元 | 5.6K | 296 |
About TG Therapeutics
关于TG Therapeutics
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.
TG Therapeutics Inc是一家完全整合的商业化阶段生物制药公司，专注于收购、开发和商业化治疗B细胞疾病的新疗法。该公司已获得美国食品和药物管理局（FDA）批准，用于治疗成人复发性多发性硬化症（RMS）的BRIUMVI（ublituximab-xiiy）。同时，该公司正在开发TG-1701（BTk抑制剂）和TG-1801（抗CD47/CD19的双特异性mAb）用于治疗B细胞疾病，目前处于一期临床试验。
Present Market Standing of TG Therapeutics
TG Therapeutics目前市场地位
- With a volume of 1,798,459, the price of TGTX is up 13.68% at $25.1.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 72 days.
- TGTX交易量为1,798,459美元，价格上涨了13.68%，目前为25.1美元。
- RSI指标暗示该股票可能要超买了。
- 下一次收益预期将在72天内发布。
What The Experts Say On TG Therapeutics
关于TG Therapeutics的专家意见
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $34.333333333333336.
在过去的一个月中，有3位行业分析师分享了他们对这支股票的看法，并提出了一个平均目标价为34.333333333333336美元。
- An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $49.
- Consistent in their evaluation, an analyst from B. Riley Securities keeps a Buy rating on TG Therapeutics with a target price of $34.
- An analyst from Goldman Sachs persists with their Neutral rating on TG Therapeutics, maintaining a target price of $20.
- HC Wainwright & Co.的一位分析师将其看涨评级下调为买入，目标价为49美元。
- 一位Riley Securities的分析师持续给TG Therapeutics买入评级，目标价为34美元。
- 高盛的一名分析师继续维持对TG Therapeutics的中立评级，维持价格目标为20美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest TG Therapeutics options trades with real-time alerts from Benzinga Pro.
期权交易具有更高的风险和潜在收益。精明的交易者通过不断学习、改进策略、监控多种因子并密切关注市场动向来管理这些风险。通过Benzinga Pro了解TG Therapeutics期权实时交易提醒。